COVID-19 Impact on Global Infectious Disease Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C103CD492648EN
QYResearch

Abstracts

This report focuses on the global Infectious Disease Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• GlaxoSmithKline
• Gilead Sciences
• Merck & Co.
• Pfizer
• Sanofi
• AbbVie
• Shire
• Grifols
• Johnson & Johnson
• Protein Sciences
• AstraZeneca

Market segment by Type, the product can be split into

• Antibacterials
• Antiviral drugs
• Antiparasitic drugs
• Antifungal
• Others

Market segment by Application, split into

• HIV
• Malaria
• Hepatitis
• Influenza
• HPV
• Tuberculosis
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Infectious Disease Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Infectious Disease Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Infectious Disease Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antibacterials
  1.4.3 Antiviral drugs
  1.4.4 Antiparasitic drugs
  1.4.5 Antifungal
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Infectious Disease Drugs Market Share by Application: 2020 VS 2026
  1.5.2 HIV
  1.5.3 Malaria
  1.5.4 Hepatitis
  1.5.5 Influenza
  1.5.6 HPV
  1.5.7 Tuberculosis
  1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Infectious Disease Drugs Industry
    1.6.1.1 Infectious Disease Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Infectious Disease Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Infectious Disease Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Infectious Disease Drugs Market Perspective (2015-2026)
2.2 Infectious Disease Drugs Growth Trends by Regions
  2.2.1 Infectious Disease Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Infectious Disease Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Infectious Disease Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Infectious Disease Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Infectious Disease Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Infectious Disease Drugs Players by Market Size
  3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2015-2020)
  3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Drugs Market Concentration Ratio
  3.2.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2019
3.3 Infectious Disease Drugs Key Players Head office and Area Served
3.4 Key Players Infectious Disease Drugs Product Solution and Service
3.5 Date of Enter into Infectious Disease Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Infectious Disease Drugs Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2021-2026)

5 INFECTIOUS DISEASE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Infectious Disease Drugs Market Size by Application (2015-2020)
5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Infectious Disease Drugs Market Size (2015-2020)
6.2 Infectious Disease Drugs Key Players in North America (2019-2020)
6.3 North America Infectious Disease Drugs Market Size by Type (2015-2020)
6.4 North America Infectious Disease Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Infectious Disease Drugs Market Size (2015-2020)
7.2 Infectious Disease Drugs Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Drugs Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Infectious Disease Drugs Market Size (2015-2020)
8.2 Infectious Disease Drugs Key Players in China (2019-2020)
8.3 China Infectious Disease Drugs Market Size by Type (2015-2020)
8.4 China Infectious Disease Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Infectious Disease Drugs Market Size (2015-2020)
9.2 Infectious Disease Drugs Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Drugs Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Infectious Disease Drugs Market Size (2015-2020)
10.2 Infectious Disease Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Infectious Disease Drugs Market Size (2015-2020)
11.2 Infectious Disease Drugs Key Players in India (2019-2020)
11.3 India Infectious Disease Drugs Market Size by Type (2015-2020)
11.4 India Infectious Disease Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Infectious Disease Drugs Market Size (2015-2020)
12.2 Infectious Disease Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Drugs Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Details
  13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
  13.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2015-2020))
  13.1.5 GlaxoSmithKline Recent Development
13.2 Gilead Sciences
  13.2.1 Gilead Sciences Company Details
  13.2.2 Gilead Sciences Business Overview and Its Total Revenue
  13.2.3 Gilead Sciences Infectious Disease Drugs Introduction
  13.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2015-2020)
  13.2.5 Gilead Sciences Recent Development
13.3 Merck & Co.
  13.3.1 Merck & Co. Company Details
  13.3.2 Merck & Co. Business Overview and Its Total Revenue
  13.3.3 Merck & Co. Infectious Disease Drugs Introduction
  13.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2015-2020)
  13.3.5 Merck & Co. Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Infectious Disease Drugs Introduction
  13.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Infectious Disease Drugs Introduction
  13.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2015-2020)
  13.5.5 Sanofi Recent Development
13.6 AbbVie
  13.6.1 AbbVie Company Details
  13.6.2 AbbVie Business Overview and Its Total Revenue
  13.6.3 AbbVie Infectious Disease Drugs Introduction
  13.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2015-2020)
  13.6.5 AbbVie Recent Development
13.7 Shire
  13.7.1 Shire Company Details
  13.7.2 Shire Business Overview and Its Total Revenue
  13.7.3 Shire Infectious Disease Drugs Introduction
  13.7.4 Shire Revenue in Infectious Disease Drugs Business (2015-2020)
  13.7.5 Shire Recent Development
13.8 Grifols
  13.8.1 Grifols Company Details
  13.8.2 Grifols Business Overview and Its Total Revenue
  13.8.3 Grifols Infectious Disease Drugs Introduction
  13.8.4 Grifols Revenue in Infectious Disease Drugs Business (2015-2020)
  13.8.5 Grifols Recent Development
13.9 Johnson & Johnson
  13.9.1 Johnson & Johnson Company Details
  13.9.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
  13.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2015-2020)
  13.9.5 Johnson & Johnson Recent Development
13.10 Protein Sciences
  13.10.1 Protein Sciences Company Details
  13.10.2 Protein Sciences Business Overview and Its Total Revenue
  13.10.3 Protein Sciences Infectious Disease Drugs Introduction
  13.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2015-2020)
  13.10.5 Protein Sciences Recent Development
13.11 AstraZeneca
  10.11.1 AstraZeneca Company Details
  10.11.2 AstraZeneca Business Overview and Its Total Revenue
  10.11.3 AstraZeneca Infectious Disease Drugs Introduction
  10.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2015-2020)
  10.11.5 AstraZeneca Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Infectious Disease Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Drugs Revenue
Table 3. Ranking of Global Top Infectious Disease Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibacterials
Table 6. Key Players of Antiviral drugs
Table 7. Key Players of Antiparasitic drugs
Table 8. Key Players of Antifungal
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Infectious Disease Drugs Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Infectious Disease Drugs Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Infectious Disease Drugs Players to Combat Covid-19 Impact
Table 15. Global Infectious Disease Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Infectious Disease Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Infectious Disease Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Infectious Disease Drugs Market Share by Regions (2015-2020)
Table 19. Global Infectious Disease Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Infectious Disease Drugs Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Infectious Disease Drugs Market Growth Strategy
Table 25. Main Points Interviewed from Key Infectious Disease Drugs Players
Table 26. Global Infectious Disease Drugs Revenue by Players (2015-2020) (Million US$)
Table 27. Global Infectious Disease Drugs Market Share by Players (2015-2020)
Table 28. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Drugs as of 2019)
Table 29. Global Infectious Disease Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Infectious Disease Drugs Product Solution and Service
Table 32. Date of Enter into Infectious Disease Drugs Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. Global Infectious Disease Drugs Market Size Share by Type (2015-2020)
Table 36. Global Infectious Disease Drugs Revenue Market Share by Type (2021-2026)
Table 37. Global Infectious Disease Drugs Market Size Share by Application (2015-2020)
Table 38. Global Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. Global Infectious Disease Drugs Market Size Share by Application (2021-2026)
Table 40. North America Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 42. North America Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. North America Infectious Disease Drugs Market Share by Type (2015-2020)
Table 44. North America Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. North America Infectious Disease Drugs Market Share by Application (2015-2020)
Table 46. Europe Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 48. Europe Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Infectious Disease Drugs Market Share by Type (2015-2020)
Table 50. Europe Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Infectious Disease Drugs Market Share by Application (2015-2020)
Table 52. China Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 53. China Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 54. China Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. China Infectious Disease Drugs Market Share by Type (2015-2020)
Table 56. China Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. China Infectious Disease Drugs Market Share by Application (2015-2020)
Table 58. Japan Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 60. Japan Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Infectious Disease Drugs Market Share by Type (2015-2020)
Table 62. Japan Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Infectious Disease Drugs Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 66. Southeast Asia Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Infectious Disease Drugs Market Share by Type (2015-2020)
Table 68. Southeast Asia Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Infectious Disease Drugs Market Share by Application (2015-2020)
Table 70. India Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 71. India Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 72. India Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. India Infectious Disease Drugs Market Share by Type (2015-2020)
Table 74. India Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. India Infectious Disease Drugs Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Infectious Disease Drugs Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Infectious Disease Drugs Market Share (2019-2020)
Table 78. Central & South America Infectious Disease Drugs Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Infectious Disease Drugs Market Share by Type (2015-2020)
Table 80. Central & South America Infectious Disease Drugs Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Infectious Disease Drugs Market Share by Application (2015-2020)
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Gilead Sciences Company Details
Table 88. Gilead Sciences Business Overview
Table 89. Gilead Sciences Product
Table 90. Gilead Sciences Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 91. Gilead Sciences Recent Development
Table 92. Merck & Co. Company Details
Table 93. Merck & Co. Business Overview
Table 94. Merck & Co. Product
Table 95. Merck & Co. Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 96. Merck & Co. Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Product
Table 100. Pfizer Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 101. Pfizer Recent Development
Table 102. Sanofi Company Details
Table 103. Sanofi Business Overview
Table 104. Sanofi Product
Table 105. Sanofi Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 106. Sanofi Recent Development
Table 107. AbbVie Company Details
Table 108. AbbVie Business Overview
Table 109. AbbVie Product
Table 110. AbbVie Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 111. AbbVie Recent Development
Table 112. Shire Company Details
Table 113. Shire Business Overview
Table 114. Shire Product
Table 115. Shire Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 116. Shire Recent Development
Table 117. Grifols Business Overview
Table 118. Grifols Product
Table 119. Grifols Company Details
Table 120. Grifols Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 121. Grifols Recent Development
Table 122. Johnson & Johnson Company Details
Table 123. Johnson & Johnson Business Overview
Table 124. Johnson & Johnson Product
Table 125. Johnson & Johnson Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 126. Johnson & Johnson Recent Development
Table 127. Protein Sciences Company Details
Table 128. Protein Sciences Business Overview
Table 129. Protein Sciences Product
Table 130. Protein Sciences Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 131. Protein Sciences Recent Development
Table 132. AstraZeneca Company Details
Table 133. AstraZeneca Business Overview
Table 134. AstraZeneca Product
Table 135. AstraZeneca Revenue in Infectious Disease Drugs Business (2015-2020) (Million US$)
Table 136. AstraZeneca Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Infectious Disease Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antibacterials Features
Figure 3. Antiviral drugs Features
Figure 4. Antiparasitic drugs Features
Figure 5. Antifungal Features
Figure 6. Others Features
Figure 7. Global Infectious Disease Drugs Market Share by Application: 2020 VS 2026
Figure 8. HIV Case Studies
Figure 9. Malaria Case Studies
Figure 10. Hepatitis Case Studies
Figure 11. Influenza Case Studies
Figure 12. HPV Case Studies
Figure 13. Tuberculosis Case Studies
Figure 14. Others Case Studies
Figure 15. Infectious Disease Drugs Report Years Considered
Figure 16. Global Infectious Disease Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Infectious Disease Drugs Market Share by Regions: 2020 VS 2026
Figure 18. Global Infectious Disease Drugs Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Infectious Disease Drugs Market Share by Players in 2019
Figure 21. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Drugs as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2019
Figure 23. North America Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Infectious Disease Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 32. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Gilead Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 34. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Merck & Co. Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pfizer Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 38. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Sanofi Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 40. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. AbbVie Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 42. Shire Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Shire Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 44. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Grifols Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 46. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Johnson & Johnson Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 48. Protein Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Protein Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AstraZeneca Revenue Growth Rate in Infectious Disease Drugs Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed